Partners-based HIV Treatment for Couples Attending Antenatal Care
2 other identifiers
interventional
2,160
1 country
1
Brief Summary
The purpose of this R01 proposal is to evaluate the clinical impact, hypothesized mechanisms of behavior change, and cost-effectiveness of a partners-focused integrated elimination of mother-to-child transmission of HIV (EMTCT) package comprised of: 1) antenatal care-based couples HIV testing, ART enrollment, and care for sero-concordant HIV+ expectant couples; (2) Couples-based treatment in the post-partum period; (3) Couple-based education and skills building; and (4) Treatment continuity with the support of expert-patient (peer) supporters from couples who have successfully navigated EMTCT. This innovative approach to scaling up EMTCT services, if proven feasible and effective, will be adopted in President's Emergency Plan for AIDS Relief (PEPFAR) programs to accelerate progress toward EMTCT and helping families with HIV infection live long, healthy lives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2017
CompletedFirst Posted
Study publicly available on registry
May 11, 2017
CompletedStudy Start
First participant enrolled
November 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 23, 2023
CompletedResults Posted
Study results publicly available
August 21, 2023
CompletedAugust 21, 2023
August 1, 2023
5.3 years
May 3, 2017
July 24, 2023
August 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of Time on Medication Among Pregnant Women
Specifically, every patient is given 30 days to pick up their medication, with a grace period of 5 days. If a patient picks up medication more than 35 days from their last pick-up, then they will be considered not on their medication from day 30 until the day of their next pick-up, at which time they will be assumed to be on medication again; this will be calculated over the course of the one-year follow-up.
12 months
Proportion of Days With Medication Among Male Partner
Proportion of days with medication (based on date of pick up and the number of pills provided by the pharmacy) among male partners
12 months
Study Arms (2)
Standard of Care
NO INTERVENTIONThe 12 clinics randomized to the control arm will continue to provide standard of care (SOC) EMTCT services that include: standard HoPS male engagement (male invitation to ANC services and couples HIV testing), opt-out rapid HIV testing of all pregnant women attending ANC, HIV-specific counseling and support for all women who test positive, provision of cotrimoxazole prophylaxis, and universal ART, as per option B+ guidelines.
Couples-based Services
EXPERIMENTALThe 12 clinics randomly assigned to the intervention arm will receive a combination of community and clinical EMTCT services, including: (1) ANC-based couples HIV testing, couples-based treatment enrollment, and clinical care for sero-concordant HIV+ expectant couples; (2) couple-centered treatment in the post-partum period at the EID clinic; (3) couples-based education and skills building during the ANC and post-partum period; and (4) treatment continuity support by expert-patient (peer) navigators selected among couples who have successfully navigated EMTCT.
Interventions
Couples-based services, including treatment, counseling and peer mentoring in the community.
Eligibility Criteria
You may qualify if:
- Couples, one HIV+ pregnant woman and her infected male partner, will be eligible to participate if the woman's due date is \>2 weeks from enrollment. Both persons must also be 18 years or older, able to give consent, willing to consent to an infant record search, and must agree to enroll in ART together.
You may not qualify if:
- Couples will not be eligible to participate in the study if the woman is not pregnant, if both persons are not HIV+, if either person is younger than 18 years, if one member of the couple is unwilling to enroll in ART or consent to the infant record search, or if one member of the couple is unable to give consent due to mental limitations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Minisitry of Health Health Facility
Pebane, Zambezia Province, Mozambique
Related Publications (2)
Audet CM, Graves E, Shepherd BE, Prigmore HL, Brooks HL, Emilio A, Matino A, Paulo P, Diemer MA, Frisby M, Sack DE, Aboobacar A, Barreto E, Van Rompaey S, De Schacht C. Partner-Based HIV Treatment for Seroconcordant Couples Attending Antenatal and Postnatal Care in Rural Mozambique: A Cluster Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):259-269. doi: 10.1097/QAI.0000000000003440.
PMID: 38905476DERIVEDSack DE, Frisby MB, Diemer MA, De Schacht C, Graves E, Kipp AM, Emilio A, Matino A, Barreto E, Van Rompaey S, Wallston KA, Audet CM. Interpersonal reactivity index adaptation among expectant seroconcordant couples with HIV in Zambezia Province, Mozambique. BMC Psychol. 2020 Aug 28;8(1):90. doi: 10.1186/s40359-020-00442-0.
PMID: 32859272DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Carolyn Audet
- Organization
- Vanderbilt University Medical Center
Study Officials
- STUDY DIRECTOR
Erin Graves, MPH, BSN
Vanderilt University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Health Policy
Study Record Dates
First Submitted
May 3, 2017
First Posted
May 11, 2017
Study Start
November 16, 2017
Primary Completion
March 1, 2023
Study Completion
July 23, 2023
Last Updated
August 21, 2023
Results First Posted
August 21, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
After the study is completed and the results published, the investigators will upload de-identified data to ICPSR.